• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
POH
Click for more information
0.00% 0.0¢

PROGRESS 2023-2 TRUST - Announcements

Market Cap $0  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
POHCAP Cancellation18/10/11
POHLegacy Executes Share Subscriotion Agreement with NMDC18/10/11
POHUpdated Company Power Point Presentation - October 201104/10/11
POHPOH to Proceed with Twice Weekly Oxycodone Patch DevelopmentPRICE SENSITIVE03/10/11
POHPOH Ready to Commence Pivital Oxycodone Clinical TrialsPRICE SENSITIVE19/09/11
POHForms 603 (2) Becoming a substantial holder15/09/11
POHPOH signs Development Deal with Global Cosmetic CompanyPRICE SENSITIVE14/09/11
POHSeptember 2011 Newsletter08/09/11
POHJune 2011 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE26/08/11
POHChange in substantial holding - Form 60426/08/11
POHNew National Stockist for ELIXIA Personal Care Product RangePRICE SENSITIVE23/08/11
PGL +Progen Subsidiary Secures New Manufacturing ContractsPRICE SENSITIVE20/07/11
POHMajor Distribution Agreement for Asia for ELIXIA ProductsPRICE SENSITIVE06/07/11
POHChange of Director's Interest Notice Appendix 3Y04/07/11
POHElixia range of Personal Care Products - UpdatePRICE SENSITIVE28/06/11
POHReconciliation of Unquoted Options06/06/11
POHResults of Annual General Meeting31/05/11
POHAGM - CEO Presentation31/05/11
POHJune 2011 Newsletter31/05/11
POHLife Science Conference Presentation26/05/11
POHPOH and 3M Collaborate to Improve Oxycodone Patch 5 FoldPRICE SENSITIVE23/05/11
CZD +Phosphagenics Bodyshaper Update17/05/11
POHLaunch of BodyShaper Cellulite Contour CremePRICE SENSITIVE17/05/11
POHAnnual Report and Notice of AGM/Proxy Form29/04/11
POHPhosphagenics moves into lucrative hair marketPRICE SENSITIVE20/04/11
POHPhosphagenics to Launch New Cellulite CosmeticsPRICE SENSITIVE11/04/11
POHPhosphagenics New ELIXIA Skincare Products Launch07/04/11
POHPhosphagenics Collaboration To Develop Anti-acne DrugPRICE SENSITIVE04/04/11
POHDecember 2010 Full Year Statutory Accounts30/03/11
POHSection 708A Cleansing Notice21/03/11
POHAppendix 3B Notice - Equity Raising18/03/11
POHEquity Raising Update16/03/11
POHEquity RaisingPRICE SENSITIVE14/03/11
POHTrading HaltPRICE SENSITIVE10/03/11
POHPhosphagenics to Partner Agricultural Company for ANZ marketPRICE SENSITIVE03/03/11
POHReplacement December 2010 Appendix 4E and Preliminary Report25/02/11
POHAppendix 4E December 2010 Preliminary Final ReportPRICE SENSITIVE25/02/11
POHPhosphagenics collaboration to develop psoriasis drugPRICE SENSITIVE07/02/11
POHPOH and Metier Tribeca LLC expand cosmetics product rangePRICE SENSITIVE27/01/11
CZD +Global launch POH Cellulite Cream 'On Track'12/01/11
POHShare Trading Policy31/12/10
POHPhosphagenics Collaborates With 3M To Develop Pain PatchPRICE SENSITIVE16/11/10
POHNovember 2010 Newsletter09/11/10
CZD +Anti-fat Peptide Patch progresses - product sales early 2011PRICE SENSITIVE19/10/10
CZD +Calzada signs Licensing deal with PhosphagenicsPRICE SENSITIVE19/10/10
POHPreparation- pain patch manufacturing after positive resultsPRICE SENSITIVE13/10/10
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604PRICE SENSITIVE02/09/10
CZD +Phosphagenics - Calzada - Exercise of optionPRICE SENSITIVE02/09/10
POHReconciliation of Unquoted Options30/08/10
POHAppendix 3X (3) and 3Z (2) Notices30/08/10
POHAvailability of Corporate Review on POH website27/08/10
POHPOH appoints three new non-executive directors24/08/10
POHJune 2010 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE13/08/10
POHPOH Presentation - BioBusiness Asia - Taiwan21/07/10
POHPhosphagenics July 2010 Newsletter15/07/10
POHPain Patch Technology Moves Forward30/06/10
POHCorporate Presentation to BioMelbourne Network08/06/10
POHNew Constitution wef 31 May 201001/06/10
POHAppendix 3Z Final Director's Interest Notice01/06/10
POHResults of Annual General Meeting31/05/10
POHChairman's and CEO Presentations to Shareholders31/05/10
POHNotice of Annual General Meeting/Proxy Form03/05/10
POHAppointment of Joint CEO - Dr Esra OgruPRICE SENSITIVE29/04/10
POHAnnual Report to shareholders23/04/10
POHChairman to Retire after AGM in May15/04/10
POHCorporate Advisor Appointmenmt and Appendix 3B Notice13/04/10
POHPOH Global Agreement with Novartis Animal HealthPRICE SENSITIVE31/03/10
POHPhosphagenics and Quigley Corp form JV for OTC ProductsPRICE SENSITIVE23/03/10
POHShareholder Update - March 2010 Newsletter18/03/10
POHResponse to an ASX Price QueryPRICE SENSITIVE17/03/10
POHDecember 2009 Appendix 4E and Statutory Financial ReportPRICE SENSITIVE19/02/10
POHPhosphagenics Launches Australian Skincare ProductsPRICE SENSITIVE03/02/10
POHPositive Results Phase 1B Study Transdermal Oxycodone PatchPRICE SENSITIVE01/02/10
POHPhosphagenics to present at ONEMEDFORUM 201008/01/10
POHReconciliation of Unquoted Options22/12/09
POHInsulin Patch On Track for Clinical TrialsPRICE SENSITIVE17/12/09
POHMetabolic Syndrome Trial ResultsPRICE SENSITIVE15/12/09
POHShareholder Update - December 2009 Newsletter04/12/09
POHOxycodone Patch - Initiation of a Phase 1B Clinical TrialPRICE SENSITIVE02/12/09
POHMajor US launch POH Personal Care Products04/11/09
POHChange in substantial holding09/10/09
POHAppendix 3Y Mr M R D Ashton05/10/09
POHAppendix 3Y Professor J Mills05/10/09
POHApprndix 3Y Notice - Associate Professor A L Vizard05/10/09
POHAppendix 3B - Share Purchase Plan05/10/09
POHShare Purchase Plan $7.0 million raising02/10/09
POHShare Purchase Plan Issue Price25/09/09
POHTransdermal Oxycodone Matrix Patch Phase 1 TrialPRICE SENSITIVE15/09/09
POHPOH to Commence Phase 2-3 Topical Diclofenac TrialPRICE SENSITIVE09/09/09
POHShare Purchase Plan documentation and Newsletter25/08/09
POHJune 2009 Half Yearly Appendix 4D and Financial ReportPRICE SENSITIVE24/08/09
POHShare Purchase Plan Variation in Underwriting Commitment18/08/09
POHUnderwritten Share Purchase PlanPRICE SENSITIVE13/08/09
POHChange in substantial holding21/07/09
POHPOH-Metier Tribeca USA cosmetics launch Le Metier de BeautePRICE SENSITIVE20/07/09
POHAppendix 3B Options - POHOB and ESOP30/06/09
POHSuccessful Completion Phase 1 Clincial using TPM/OxycodonePRICE SENSITIVE29/06/09
POHResults of Annual General Meeting29/05/09
POHChairman's and COO's Address to Shareholders29/05/09
POHCompletion - Transdermal Patch Prototypes - OxycodonePRICE SENSITIVE29/05/09
POHCAP Cancellation
18/10/11
POHLegacy Executes Share Subscriotion Agreement with NMDC
18/10/11
POHUpdated Company Power Point Presentation - October 2011
04/10/11
POHPOH to Proceed with Twice Weekly Oxycodone Patch Development
03/10/11PRICE SENSITIVE
POHPOH Ready to Commence Pivital Oxycodone Clinical Trials
19/09/11PRICE SENSITIVE
POHForms 603 (2) Becoming a substantial holder
15/09/11
POHPOH signs Development Deal with Global Cosmetic Company
14/09/11PRICE SENSITIVE
POHSeptember 2011 Newsletter
08/09/11
POHJune 2011 Half Yearly Appendix 4D and Financial Report
26/08/11PRICE SENSITIVE
POHChange in substantial holding - Form 604
26/08/11
POHNew National Stockist for ELIXIA Personal Care Product Range
23/08/11PRICE SENSITIVE
PGL +Progen Subsidiary Secures New Manufacturing Contracts
20/07/11PRICE SENSITIVE
POHMajor Distribution Agreement for Asia for ELIXIA Products
06/07/11PRICE SENSITIVE
POHChange of Director's Interest Notice Appendix 3Y
04/07/11
POHElixia range of Personal Care Products - Update
28/06/11PRICE SENSITIVE
POHReconciliation of Unquoted Options
06/06/11
POHResults of Annual General Meeting
31/05/11
POHAGM - CEO Presentation
31/05/11
POHJune 2011 Newsletter
31/05/11
POHLife Science Conference Presentation
26/05/11
POHPOH and 3M Collaborate to Improve Oxycodone Patch 5 Fold
23/05/11PRICE SENSITIVE
CZD +Phosphagenics Bodyshaper Update
17/05/11
POHLaunch of BodyShaper Cellulite Contour Creme
17/05/11PRICE SENSITIVE
POHAnnual Report and Notice of AGM/Proxy Form
29/04/11
POHPhosphagenics moves into lucrative hair market
20/04/11PRICE SENSITIVE
POHPhosphagenics to Launch New Cellulite Cosmetics
11/04/11PRICE SENSITIVE
POHPhosphagenics New ELIXIA Skincare Products Launch
07/04/11
POHPhosphagenics Collaboration To Develop Anti-acne Drug
04/04/11PRICE SENSITIVE
POHDecember 2010 Full Year Statutory Accounts
30/03/11
POHSection 708A Cleansing Notice
21/03/11
POHAppendix 3B Notice - Equity Raising
18/03/11
POHEquity Raising Update
16/03/11
POHEquity Raising
14/03/11PRICE SENSITIVE
POHTrading Halt
10/03/11PRICE SENSITIVE
POHPhosphagenics to Partner Agricultural Company for ANZ market
03/03/11PRICE SENSITIVE
POHReplacement December 2010 Appendix 4E and Preliminary Report
25/02/11
POHAppendix 4E December 2010 Preliminary Final Report
25/02/11PRICE SENSITIVE
POHPhosphagenics collaboration to develop psoriasis drug
07/02/11PRICE SENSITIVE
POHPOH and Metier Tribeca LLC expand cosmetics product range
27/01/11PRICE SENSITIVE
CZD +Global launch POH Cellulite Cream 'On Track'
12/01/11
POHShare Trading Policy
31/12/10
POHPhosphagenics Collaborates With 3M To Develop Pain Patch
16/11/10PRICE SENSITIVE
POHNovember 2010 Newsletter
09/11/10
CZD +Anti-fat Peptide Patch progresses - product sales early 2011
19/10/10PRICE SENSITIVE
CZD +Calzada signs Licensing deal with Phosphagenics
19/10/10PRICE SENSITIVE
POHPreparation- pain patch manufacturing after positive results
13/10/10PRICE SENSITIVE
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604
02/09/10PRICE SENSITIVE
CZD +Phosphagenics - Calzada - Exercise of option
02/09/10PRICE SENSITIVE
POHReconciliation of Unquoted Options
30/08/10
POHAppendix 3X (3) and 3Z (2) Notices
30/08/10
POHAvailability of Corporate Review on POH website
27/08/10
POHPOH appoints three new non-executive directors
24/08/10
POHJune 2010 Half Yearly Appendix 4D and Financial Report
13/08/10PRICE SENSITIVE
POHPOH Presentation - BioBusiness Asia - Taiwan
21/07/10
POHPhosphagenics July 2010 Newsletter
15/07/10
POHPain Patch Technology Moves Forward
30/06/10
POHCorporate Presentation to BioMelbourne Network
08/06/10
POHNew Constitution wef 31 May 2010
01/06/10
POHAppendix 3Z Final Director's Interest Notice
01/06/10
POHResults of Annual General Meeting
31/05/10
POHChairman's and CEO Presentations to Shareholders
31/05/10
POHNotice of Annual General Meeting/Proxy Form
03/05/10
POHAppointment of Joint CEO - Dr Esra Ogru
29/04/10PRICE SENSITIVE
POHAnnual Report to shareholders
23/04/10
POHChairman to Retire after AGM in May
15/04/10
POHCorporate Advisor Appointmenmt and Appendix 3B Notice
13/04/10
POHPOH Global Agreement with Novartis Animal Health
31/03/10PRICE SENSITIVE
POHPhosphagenics and Quigley Corp form JV for OTC Products
23/03/10PRICE SENSITIVE
POHShareholder Update - March 2010 Newsletter
18/03/10
POHResponse to an ASX Price Query
17/03/10PRICE SENSITIVE
POHDecember 2009 Appendix 4E and Statutory Financial Report
19/02/10PRICE SENSITIVE
POHPhosphagenics Launches Australian Skincare Products
03/02/10PRICE SENSITIVE
POHPositive Results Phase 1B Study Transdermal Oxycodone Patch
01/02/10PRICE SENSITIVE
POHPhosphagenics to present at ONEMEDFORUM 2010
08/01/10
POHReconciliation of Unquoted Options
22/12/09
POHInsulin Patch On Track for Clinical Trials
17/12/09PRICE SENSITIVE
POHMetabolic Syndrome Trial Results
15/12/09PRICE SENSITIVE
POHShareholder Update - December 2009 Newsletter
04/12/09
POHOxycodone Patch - Initiation of a Phase 1B Clinical Trial
02/12/09PRICE SENSITIVE
POHMajor US launch POH Personal Care Products
04/11/09
POHChange in substantial holding
09/10/09
POHAppendix 3Y Mr M R D Ashton
05/10/09
POHAppendix 3Y Professor J Mills
05/10/09
POHApprndix 3Y Notice - Associate Professor A L Vizard
05/10/09
POHAppendix 3B - Share Purchase Plan
05/10/09
POHShare Purchase Plan $7.0 million raising
02/10/09
POHShare Purchase Plan Issue Price
25/09/09
POHTransdermal Oxycodone Matrix Patch Phase 1 Trial
15/09/09PRICE SENSITIVE
POHPOH to Commence Phase 2-3 Topical Diclofenac Trial
09/09/09PRICE SENSITIVE
POHShare Purchase Plan documentation and Newsletter
25/08/09
POHJune 2009 Half Yearly Appendix 4D and Financial Report
24/08/09PRICE SENSITIVE
POHShare Purchase Plan Variation in Underwriting Commitment
18/08/09
POHUnderwritten Share Purchase Plan
13/08/09PRICE SENSITIVE
POHChange in substantial holding
21/07/09
POHPOH-Metier Tribeca USA cosmetics launch Le Metier de Beaute
20/07/09PRICE SENSITIVE
POHAppendix 3B Options - POHOB and ESOP
30/06/09
POHSuccessful Completion Phase 1 Clincial using TPM/Oxycodone
29/06/09PRICE SENSITIVE
POHResults of Annual General Meeting
29/05/09
POHChairman's and COO's Address to Shareholders
29/05/09
POHCompletion - Transdermal Patch Prototypes - Oxycodone
29/05/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.0¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.